Nuzenio

Led Attovia Therapeutics

Led Attovia Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 17 latest news signals 14 publisher sources 100/100 entity strength

Latest news

Timeline

Thu, 06 Aug 2026 21:54:48 GMTAttovia Therapeutics raises $332M in upsized IP... - Pluang
Thu, 06 Aug 2026 20:14:27 GMTAttovia Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Manila Times
Thu, 06 Aug 2026 10:46:00 GMTImmune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on Nasdaq - Yahoo Finance
Thu, 06 Aug 2026 09:57:00 GMTAttovia IPO Proceeds Will Advance Three Immune-Mediated Candidates - Stock Titan
Thu, 06 Aug 2026 08:26:00 GMTImmunotherapy Startup Attovia Lists on Nasdaq: IPO Raises $289 Million, First-Day Market Cap Tops $900 Million - finance.biggo.com
Wed, 05 Aug 2026 20:58:00 GMTFenwick-Led Attovia Therapeutics Prices Upsized $289M IPO - Law360

Related explainers

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Led Attovia Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

14 distinct publisher/source names are currently connected to this entity page.